Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) are treated with drugs that may impact their immune responses to SARS-CoV-2 vaccines. We describe here the anti-Spike (anti-S) IgG and neutralizing antibody responses induced by the mRNA-1273 SARS-CoV-2 vaccine in a 78-years-old patient with RA, who received a...

Descripción completa

Detalles Bibliográficos
Autores principales: Michiels, Yves, Houhou-Fidouh, Nadhira, Collin, Gilles, Berger, Jérôme, Kohli, Evelyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402486/
https://www.ncbi.nlm.nih.gov/pubmed/34452007
http://dx.doi.org/10.3390/vaccines9080883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402486/
https://www.ncbi.nlm.nih.gov/pubmed/34452007
http://dx.doi.org/10.3390/vaccines9080883

Ejemplares similares